We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Ardmore Shipping
ASC
$678M
| $6.59M | 0.01% |
890,088
+242,470
| +37% | +$1.62M |
|
452
Federal Agricultural Mortgage
AGM
$2.27B
| $6.54M | 0.01% |
114,200
-169,384
| -60% | -$8.25M |
|
|
WLB
453
DELISTED
Westmoreland Coal Company
WLB
| $6.42M | 0.01% |
363,150
-356,300
| -50% | -$4.97M |
|
454
CareTrust REIT
CTRE
$10.2B
| $6.4M | 0.01% |
417,740
+195,920
| +88% | +$2.8M |
|
455
Rio Tinto
RIO
$148B
| $6.36M | 0.01% |
165,477
+136
| +0.1% | +$4.99K |
|
|
AMAG
456
DELISTED
AMAG Pharmaceuticals
AMAG
| $6.34M | 0.01% |
182,301
| – | – |
|
|
VCRA
457
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $6.33M | 0.01% |
342,520
-85,370
| -20% | -$1.52M |
|
458
Lifecore Biomedical
LFCR
$162M
| $6.26M | 0.01% |
453,510
-203,050
| -31% | -$2.81M |
|
|
SJI
459
DELISTED
South Jersey Industries, Inc.
SJI
| $6.26M | 0.01% |
185,770
-2,210
| -1% | -$69K |
|
460
Lazard
LAZ
$4.37B
| $6.24M | 0.01% |
151,926
| – | – |
|
461
Chesapeake Utilities
CPK
$3.26B
| $6.21M | 0.01% |
92,827
+12,677
| +16% | +$810K |
|
|
RELY
462
DELISTED
Real Industry, Inc.
RELY
| $6.14M | 0.01% |
1,007,140
-64,280
| -6% | -$373K |
|
463
iShares Russell 1000 Value ETF
IWD
$82B
| $6.08M | 0.01% |
54,300
-7,995
| -13% | -$864K |
|
|
MJN
464
DELISTED
Mead Johnson Nutrition Company
MJN
| $6.05M | 0.01% |
85,500
| – | – |
|
465
Hope Bancorp
HOPE
$1.72B
| $6.04M | 0.01% |
276,060
+7,476
| +3% | +$141K |
|
466
POSCO
PKX
$15.8B
| $6.02M | 0.01% |
114,531
| – | – |
|
|
MR
467
DELISTED
Montage Resources Corporation Common Stock
MR
| $5.99M | 0.01% |
149,463
+31,938
| +27% | +$1.42M |
|
|
TIS
468
DELISTED
Orchids Paper Products, Inc.
TIS
| $5.97M | 0.01% |
228,072
+6,161
| +3% | +$159K |
|
469
Saic
SAIC
$5.03B
| $5.93M | 0.01% |
69,984
| – | – |
|
470
ATI
ATI
$27B
| $5.93M | 0.01% |
372,470
+62,600
| +20% | +$1.04M |
|
471
The GEO Group
GEO
$4.13B
| $5.93M | 0.01% |
247,710
-214,860
| -46% | -$4.18M |
|
472
Alto Ingredients
ALTO
$360M
| $5.92M | 0.01% |
623,540
+123,420
| +25% | +$991K |
|
473
Freeport-McMoran
FCX
$90B
| $5.89M | 0.01% |
446,897
| – | – |
|
474
Procter & Gamble
PG
$343B
| $5.89M | 0.01% |
70,000
+25,187
| +56% | +$2.15M |
|
475
AMERISAFE
AMSF
$569M
| $5.87M | 0.01% |
94,156
+2,518
| +3% | +$153K |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.